Background. Tetanus-diphtheria-acellular pertussis (Tdap) and influenza (flu) vaccines are recommended for all pregnant women in each pregnancy. However, vaccination uptake is suboptimal. Our objective was to test of the efficacy of an online vaccine and social media resource in increasing uptake of Tdap and flu vaccines.
Background. Obstetrician-gynecologists (ob-gyns) play a crucial role as vaccinators of pregnant women, yet little is known about their attitudes and practices in this role. Our objectives were to describe, among a nationally representative sample of ob-gyns: 1) practices and attitudes regarding vaccination of pregnant women; and 2) barriers to the use of standing orders.
Methods. An e-mail and mail survey among ob-gyns conducted March-June 2016.
Results. The response rate was 69% (331/477). Overall, 90% reported administering ≥1 vaccines to pregnant women. Almost all (97% and 95%, respectively), strongly recommend influenza (flu) and tetanus-diphtheria-acellular pertussis (Tdap) vaccines; 60% use standing orders for flu vaccination and 56% for Tdap vaccination. More (68%) always recommend Tdap vaccines to household contacts of pregnant women than flu vaccines (53%). Physician attitudes are shown in the figure.
The most significant barriers to the use of standing orders included provider concern that patients prefer to speak to them first (12% major barrier, 25% somewhat), provider belief that they should be the one to recommend vaccines (11% major, 12% somewhat), and staff discomfort because of having to answer vaccine-related questions (7% major, 17% somewhat).
Conclusion. Ob-gyn attitudinal barriers to maternal vaccination are rare, whereas barriers to use of standing orders, a highly effective strategy for increasing vaccination uptake, are common, and less than 2/3 of providers currently use them.
Disclosures. All authors: No reported disclosures. Methods. 34 healthy mother-infant pairs were followed prospectively from maternal Tdap immunization to infant age 6 weeks. Blood was collected from women pre-Tdap, 4 weeks post Tdap and at delivery, and from infants at birth, and age 3 and 6 weeks. IgG to pertussis toxin (PT), filamentous hemagglutinin (FHA), fimbrial proteins (FIM) and pertactin (PRN) was quantified by luminex assay (IU/mL). Geometric mean concentrations (GMCs) with 95% confidence intervals (C.I.) for pertussis-specific IgG and half-life of IgG to PT were calculated.
Durability and Kinetics of Maternal Pertussis Antibodies in Infants of
Results. Mean maternal age was 31.1 years (range 22.7-39.7); 47% were white, 32% Hispanic and 21% Black. Tdap was administered at a mean gestation of 30.7 weeks (28-32.7). Infants had a mean gestation of 39.1 weeks (36-41.1) and birthweight of 3379g (2580-4584). GMCs (95%C.I.) for maternal pertussis-specific IgG increased significantly 4 weeks post-Tdap (4-fold higher in 59%, 41%, 29% and 44% for PT, FHA, FIM and PRN, respectively) and waned before delivery. Placental transfer was 135% for PT, 141% for FHA, 131% for FIM and 136% for PRN. Maternal antibodies in infants decayed quickly, but at age 6 weeks GMC of infant PT-specific IgG was 21.1IU/mL (14.7-30.2) and 91% had PT ≥ 10 IU/mL. Estimated half-life of PT-specific IgG in infants was 30.9 days. 
Conclusion.
Although the half-life of maternal PT-specific antibodies induced by Tdap immunization during the third trimester of pregnancy is shorter than previously thought, this strategy results in levels likely sufficient to protect infants through the start of the immunization series.
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